WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018004477) SURFACTANTS FOR TREATMENT OF SKIN INFECTIONS CAUSED BY DOUBLE STRANDED DNA VIRUSES OF THE HERPESVIRIDAE OR PAPILLOMAVIRIDAE FAMILIES
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2018/004477    International Application No.:    PCT/TR2016/050200
Publication Date: 04.01.2018 International Filing Date: 28.06.2016
IPC:
A61K 31/185 (2006.01), A61P 31/20 (2006.01), A61P 31/22 (2006.01), A61K 47/32 (2006.01), A61K 47/34 (2017.01), A61K 47/36 (2006.01), A61K 47/38 (2006.01)
Applicants: PISAK, Mehmet Nevzat [TR/TR]; (TR)
Inventors: PISAK, Mehmet Nevzat; (TR)
Agent: DERIS PATENTS AND TRADEMARKS AGENCY A.S.; Inebolu Sokak, No. 5, Deris Patent Building Kabatas Setustu 34427 Istanbul (TR)
Priority Data:
Title (EN) SURFACTANTS FOR TREATMENT OF SKIN INFECTIONS CAUSED BY DOUBLE STRANDED DNA VIRUSES OF THE HERPESVIRIDAE OR PAPILLOMAVIRIDAE FAMILIES
(FR) TENSIOACTIFS POUR LE TRAITEMENT D'INFECTIONS DE LA PEAU CAUSÉES PAR DES VIRUS À ADN DOUBLE BRIN DES FAMILLES DES HERPESVIRIDAE OU DES PAPILLOMAVIRUS
Abstract: front page image
(EN)The present invention relates to a surfactant, or a pharmaceutically acceptable salt or a stereoisomer thereof, and a composition including the surfactant, for post infection treatment of a double stranded DNA skin virus from the Herpesviridae or Papillomaviridae families. The composition may comprise an anionic or amphoteric surfactant, or a pharmaceutically acceptable salt or a stereoisomer thereof, wherein the surfactant further comprises: a hydrophilic moiety selected from the group consisting of a carbonate, a sulfonate, and a sulfate; a polyol compound and/or a cross-linked polyacrylate polymer; and at least one pharmaceutically acceptable excipient. Methods of using the surfactant and composition are also disclosed.
(FR)La présente invention concerne un tensioactif, ou un sel pharmaceutiquement acceptable ou un stéréoisomère de celui-ci, et une composition comprenant le tensioactif, pour le traitement post-infection d'un virus cutané à ADN double brin des familles des Herpesviridae ou des Papillomavirus. La composition peut comprendre un tensioactif anionique ou amphotère, ou un sel pharmaceutiquement acceptable ou un stéréoisomère de celui-ci, le tensioactif comprenant en outre : une fraction hydrophile choisie dans le groupe constitué d'un carbonate, un sulfonate et un sulfate; un composé polyol et/ou un polymère de polyacrylate réticulé; et au moins un excipient pharmaceutiquement acceptable. L'invention concerne en outre des procédés d'utilisation du tensioactif et de la composition.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)